← Leaderboards
Lauren Elaine Brown
University Of Toronto
$5,536,018
Attributed
$12,137,241
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,137,241 · 4
By mechanism
R01$12,137,241 · 4
Top collaborators
- Leah Elizabeth Cowen8 shared
- Scott Edward Schaus5 shared
- Damian J Krysan3 shared
- John H Connor1 shared
- Luke J Whitesell1 shared
Most similar at University Of Toronto
Same institution · by research overlap
- Leah Elizabeth Cowen$8,295,527
Others in their field
Top investigators on “Small Molecule”
- David Heimbrook · Leidos Biomedical Research, Inc.$251,072,489
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$143,645,434
- Mark S Klempner · Tufts Medical Center$128,021,180
- Stuart L Schreiber · Harvard University (Medical School)$79,067,419
- Edward A Dennis · University Of California, San Diego$73,030,813
Research focus
Small MoleculeLeadBiologyStructure-Activity RelationshipInfectionPharmaceutical PreparationsToxic EffectDrug KineticsCellsAnalogDesignAffinityDrug CandidateRouteResistanceDosePre-ClinicalPersonsCollaborationsPharmacologyIn VivoMolecular TargetGeneticAffect
Grant awards (14)
Advancement of a poxvirus antiviral$2,607,328
R01 · FY2025 · AI
Targeting the Genus Leishmania with Small Molecules$704,821
R01 · FY2025 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$650,345
R01 · FY2025 · AI
Targeting the Genus Leishmania with Small Molecules$723,268
R01 · FY2024 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$653,100
R01 · FY2024 · AI
Targeting the Genus Leishmania with Small Molecules$751,549
R01 · FY2023 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$655,235
R01 · FY2023 · AI
Targeting the Genus Leishmania with Small Molecules$764,245
R01 · FY2022 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$623,188
R01 · FY2022 · AI
Targeting the Genus Leishmania with Small Molecules$808,549
R01 · FY2021 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$777,729
R01 · FY2019 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$796,231
R01 · FY2018 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$817,242
R01 · FY2017 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis$804,411
R01 · FY2016 · AI